Gold, L. S., J. S. Weiss, L. Green, L. Kircik, L. Miller, A. Jacobson, and S. Harris. “Long-Term Management of Moderate-to-Severe Plaque Psoriasis: Maintenance of Treatment Success Following Cessation of Fixed Combination Halobetasol Propionate 0.01% and Tazarotene 0.045% (HP/TAZ) Lotion in Patients With Baseline Body Surface Area of 6 -12%”. SKIN The Journal of Cutaneous Medicine, vol. 4, no. 5, Sept. 2020, p. s37, doi:10.25251/skin.4.supp.37.